1.
False. Currently a preventive HIV vaccine does
not exist. Ongoing research is being conducted to find a safe and effective vaccine.
2. False. Everyone should be concerned about an HIV vaccine. HIV has no
boundaries. The highest rates of new infection in the U.S. are in African Americans,
Latinos/as, men who have sex with men, injection drug users (IDUs) and sexual
partners of IDUs.
3. False. Vaccines being used in human trials cannot cause HIV infection
or AIDS.
4. False. In order to participate in an HIV vaccine clinical trial you cannot
be HIV+. Preventive HIV vaccines for HIV- negative populations are being developed
to control the spread of HIV and are not a cure for AIDS.
5. True. All clinical trial participants are told of the known side effects
that may occur through a process known as Informed Consent. Informed Consent explains
the possible risks and benefits of participation, the process of trial participation
and everything else involved with trial participation. It is required of all volunteers.
In addition, Informed Consent makes it clear that participating in a trial is
completely voluntary and that a trial participant can withdraw consent and stop
their participation at any time.
6. True. All preventive vaccines go through a rigorous testing process including
a pre-clinical phase involving animals and then three different phases involving
humans before the Food and Drug Administration can approve it.
7. True. Scientists believe that an effective preventive HIV vaccine, given
before exposure to HIV, could have a number of possible outcomes, including:
Preventing infection in most people;
Preventing infection in some people;
Preparing a person's immunes system to block continued infection and eliminate
the virus (vaccines against measles, mumps and polio work this way);
Delaying or preventing the onset of illness or AIDS.
8. True. Researchers are also evaluating therapeutic vaccines designed to
treat HIV+ individuals or people living with AIDS.
9. False. All trial participants receive extensive counseling regarding safer
behaviors and ways to reduce their risk of infection throughout the trial. Participants
can only be exposed to HIV through their own behavior, and never through the vaccine
or through the trial.
10. False. While racial and ethnic minorities comprise a majority of new
cases of HIV infection in the United States, they are underrepresented in preventive
HIV vaccine trials.